Target nearly reached for tourette syndrome sufferer

Add a comment
Adam Belcher, 29, is the first person in New Zealand with Tourette Syndrome (TS) to be granted a prescription for Sativex (medicinal cannabis spray). Photo/file
Adam Belcher, 29, is the first person in New Zealand with Tourette Syndrome (TS) to be granted a prescription for Sativex (medicinal cannabis spray). Photo/file

Less than $600 needs to be raised on Givealittle website to give Tauranga Tourette syndrome sufferer Adam Belcher the $3300 he needs to purchase more of a 'miracle' medicine.

The 29-year-old Tauranga man became the first New Zealander with Tourettes to be allowed to use the medicinal cannabis spray Sativex, but after paying for two prescriptions out of his own pocket and a third thanks to an anonymous donor, he faced the dreaded prospect of losing the treatment approved for him by Health Minister Jonathan Coleman.

Read more: 'Miracle' med too costly for patient

He needed to raise $3300 to buy a six-month subscription course of the non-funded medicine and so far 77 donors have contributed $2720 on Givealittle.

Savitex has given him a life free of pain and physically and socially crippling tics.

Video

- Bay of Plenty Times

Get the news delivered straight to your inbox

Receive the day’s news, sport and entertainment in our daily email newsletter

SIGN UP NOW

Have your say

1200 characters left

By and large our readers' comments are respectful and courteous. We're sure you'll fit in well.
View commenting guidelines.

© Copyright 2016, NZME. Publishing Limited

Assembled by: (static) on production bpcf05 at 27 Sep 2016 14:37:08 Processing Time: 416ms